When I pull up a quote for Neuren, it shows a PE of 25 based upon EPS of 0.44 and a stock price of $11. The product of the EPS and the PE is $11. So someone in investor land is bestowing a PE of 25. Questions for the Board - is there any legitimacy to an EPS of 0.44? Is that past or projected earnings, and shouldn’t it be projected earnings? With Acadia announcing Q3 at or about November 2 along with projected Q4, what would the share price be based upon a forward looking PE of 25, and with whatever methodology is currently at play? Thank you in advance.
Share Price, page-7271
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.40 |
Change
1.130(8.52%) |
Mkt cap ! $1.840B | |||
| Open | High | Low | Value | Volume |
| $13.80 | $14.45 | $13.53 | $15.04M | 1.062M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 871 | $14.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.42 | 3650 | 3 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |